1 week ago
ImmunityBio (IBRX) Stock Surges Following UAE Cancer Treatment Approval
ImmunityBio (IBRX) stock climbs after UAE approves ANKTIVA for bladder and lung cancer treatment, extending regulatory footprint to 34 global markets.
The post ImmunityBio (IBRX) Stock Surges Following UAE Cancer Treatment Approval appeared first on Blockonomi.
Source: Blockonomi →Related News
- 16 hours ago
AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal
- 16 hours ago
Tempus AI (TEM) Stock Soars 11% on Groundbreaking Cancer AI Study and Quarterly...
- 16 hours ago
Uber (UBER) Stock Surges on Q2 Earnings Beat: Is the Rally Sustainable?
- 17 hours ago
QuantumScape (QS) Stock Surges 16.5% This Week Despite Lack of News
- 17 hours ago
Westwater Resources (WWR) Stock Soars 88% on $25M Federal Financing Deal